Literature DB >> 1649548

Expression, structure, and function of the CD23 antigen.

G Delespesse1, U Suter, D Mossalayi, B Bettler, M Sarfati, H Hofstetter, E Kilcherr, P Debre, A Dalloul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1649548     DOI： 10.1016/s0065-2776(08)60776-2

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  37 in total

1.  Elevated soluble CD23 levels in the sera from patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; K Kikuchi; H Ihn; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

Review 2.  CD23: novel disease marker with a split personality.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 3.  Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.

Authors:  Dong Liu; Jian-Ying Zhu; Zhong-Xiang Niu
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

4.  Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways.

Authors:  F Ouaaz; F W Ruscetti; B Dugas; J Mikovits; H Agut; P Debré; M D Mossalayi
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

5.  Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).

Authors:  M Itoh; K Uchimura; N Hayakawa; M Makino; R Hayashi; M Nagata; H Kakizawa; A Nagasaka; H Sakamoto; H Kuzuya
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23.

Authors:  V Roman; N Dugas; A Abadie; C Amirand; H Zhao; B Dugas; J P Kolb
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

7.  Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40.

Authors:  A Katira; K A Knox; M Finney; R H Michell; M Wakelam; J Gordon
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes.

Authors:  P A Bécherel; M D Mossalayi; F Ouaaz; L Le Goff; B Dugas; N Paul-Eugène; C Frances; O Chosidow; E Kilchherr; J J Guillosson
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen.

Authors:  I Vouldoukis; V Riveros-Moreno; B Dugas; F Ouaaz; P Bécherel; P Debré; S Moncada; M D Mossalayi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution.

Authors:  R L Beavil; P Graber; N Aubonney; J Y Bonnefoy; H J Gould
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.